Lupin Pharmaceuticals Inc. recalls Rifampin Capsules USP, 300 mg, 30-count bottle; Rx Only, Manufactured for: Lupin Pharmaceuticals Baltimore, Maryland 212
Recalled January 18, 2023 · FDA recall D-0100-2023 · Lupin Pharmaceuticals
Hazard
Failed Impurities/Degradation Specifications: Failure observed in related substance testing during long term stability study. · FDA Class II
Units
16,056 30 count bottles
Sold at
Distributed Nationwide in the USA
Description
Failed Impurities/Degradation Specifications: Failure observed in related substance testing during long term stability study.
Product
Rifampin Capsules USP, 300 mg, 30-count bottle; Rx Only, Manufactured for: Lupin Pharmaceuticals Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India. NDC 68180-659-06
Manufacturer(s)
Lupin Pharmaceuticals Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →